The first DISARM Newsletter is here! 📩
In the first edition, we’re sharing highlights from our first 6 months — from project launch and collaboration to early research progress in ovarian cancer detection 💙
disarm-project.eu/2026/03/31/d...
#HaDEA #CancerMission
Missed this last week?
ESGO is calling for systemic reform in women’s cancer care across Europe, and DISARM is already helping move that forward 🩺
Read more: disarm-project.eu/2026/03/03/a...
#HaDEA #CancerMission
Today on #InternationalWomensDay, we celebrate the incredible women of DISARM, and honour the strength of patients and families whose courage inspires our work💙
Happy International Women's Day! 👩🏫👩💼👩🔬
#HaDEA #CancerMission
The Quality of Life (AYA) Cluster meeting brought together several EU-funded projects in Brussels this week to strengthen collaboration on AYA cancer survivorship.
TRANSCEND-XR was pleased to contribute to these exchanges.
#CancerMission #QoLAYACluster
We had the pleasure to contribute to 2 important EU #CancerMission events on improving quality of life for Adolescent and Young Adult #AYA #cancersurvivors organised by @ec.europa.eu. Great to connect with collaborators like @transcend-xr.bsky.social and @youthcancereurope.bsky.social. More soon!
🎥 Final interview from the DISARM kick-off in Athens! 🇬🇷
Project Coordinator @dimitra-dionysiou.bsky.social shares her role, what excites her about the project, and the consortium’s ambitious goals.
Watch now 🎬
#HaDEA #CancerMission
www.youtube.com/watch?v=ZWjX...
🚨 Athens Digital Health Week, Mon 16th!
The EARLYSCAN Cluster is hosting a hands-on workshop: "Early Detection & Personalised Cancer Care"
Digital health/AI/cancer folks - join us & help shape the future!
athensdigitalhealth.eu
#HaDEA #CancerMission #AthensDigitalHealthWeek
A new @politico.eu article highlights the rising burden & the need for action on ovarian cancer, featuring DISARM as a promising step toward earlier detection and better risk assessment 🩺
#HaDEA #CancerMission
🔗 www.politico.eu/sponsored-co...
On #WorldCancerDay, DISARM highlights the urgent challenge of #OvarianCancer — often diagnosed late, with limited early detection options.
Find out how we are working to improve risk assessment & early detection 🔍
🔗 disarm-project.eu/2026/01/29/w...
#HaDEA #CancerMission
The Lancet Commission on Ovarian Cancer calls for earlier identification of women at increased risk, including genetic testing and personalised risk tools, aligning closely with DISARM’s focus on early detection 🧬
#HaDEA #CancerMission
www.thelancet.com/journals/lan...
Proud to see DISARM featured in the latest newsletter from our partner the World Ovarian Cancer Coalition, as part of their reflections on 2026 and the next decade of action on ovarian cancer 💙
Check out the full newsletter below! 🗞️
#HaDEA #CancerMission
We will work for:
•Strengthening ethical and legal frameworks in cancer research
•Promoting inclusive stakeholder engagement
•Identifying best practices for innovation aligned with societal needs
📢 Follow us for updates, insights, and opportunities to collaborate
Collaboration is key! #CancerMission
🚀 Introducing PERIFORMANCE! A pioneering project shaping stakeholder engagement in cancer research by embedding #ELSI into EU MISSIONS approach.
Follow us for updates 👉 periformance.com
#CancerMission #AI #HealthData #Innovation
DISARM partner VOC Diagnostics helps to show that ovarian cancer can be detected from blood plasma using an AI-driven electronic nose - no biomarkers needed.
Exactly the innovation we need for earlier detection 💙
🔗Read more: researchgate.net/publication/...
#HaDEA #CancerMission
🎥 DISARM Interview Series – Episode 3
We spoke with Fatima Vaz on IPOLisboa’s role in DISARM, her expertise as a medical oncologist, and the innovative technologies being tested as part of the project.
🎬 Watch: youtu.be/Hpjs6EqzfdE
#HaDEA #CancerMission
🎥 Our second DISARM interview video is live!
In this video, Laura Caretto of EVITA discusses her role in the project, the project's Citizen Awareness Campaign, and what she is most excited about as DISARM moves forward.
🎬 Watch the interview here: youtu.be/i3pRl4qngjY?...
#HaDEA #CancerMission
🎁 It’s time to unwrap our Christmas present!
The official DISARM project website is now live — bringing together our mission, partners & progress in one place.
🔗 Visit: Home | disarm-project.eu
#HaDEA #CancerMission
🎅 An early holiday surprise…
The DISARM project’s official website is launching very soon, bringing together all our project information, project partners, and updates in one place.
Stay tuned — the wrapping is coming off shortly! 🎁
#HaDEA #CancerMission
We’re pleased to share that Zdenek Kleibl of @charlesuni.cuni.cz took part in the 2025 CSBMB Annual Symposium in Nanchang, China (23–26 Oct).
He also presented the DISARM project, sharing its goals and research with an international audience.
📸 Photos below!
#HaDEA #CancerMission
Knowing the symptoms of #OvarianCancer can save lives — please take a moment to watch and share @targetovarian.bsky.social's video over on X and visit their website so more people can recognise the signs early. 💙
#HaDEA #CancerMission
x.com/i/status/199...
We were thrilled to present the DISARM project at IPO Lisbon on 31st October! 🎉
If you weren’t able to attend but want to learn more, please feel free to contact the Communication and Dissemination Manager, Ben Moore, at bmoore@carrcommunications.ie
#HaDEA #CancerMission
We are proud to share that the @cancerletter.com has featured the first press release from DISARM 📰
A big thank you to them for helping spread word of our project that aims to advance early detection & risk assessment for ovarian cancer 💙
#HaDEA #CancerMission
cancerletter.com/clinical-rou...
On October 31, the DISARM project will be presented at the IPO Lisbon Research Meeting, introducing a major step forward in the early detection of ovarian cancer.
✍️Sign up here: lnkd.in/dTfRAinJ
#HaDEA #CancerMission
We’re proud to share that ecancer, a leading oncology education platform, has featured the first press release from DISARM — our EU-funded project focused on improving risk assessment and early detection in ovarian cancer 📰
#HaDEA #CancerMission
ecancer.org/en/news/2717...
Besides 🇬🇧, you can also take the survey in:
🇫🇷 forms.gle/84NuHZeesJwE...
🇺🇦 forms.gle/cx2EDVzvZrqJ...
🇪🇸 forms.gle/84NuHZeesJwE...
Your feedback shapes the future of trusted cancer information. #CancerMission #CancerAwareness
@europeancancer.bsky.social @youthcancereurope.bsky.social
🚨Reminder! Horizon Europe Health and #CancerMission calls close on 16 September 2025.
📋Don't miss your chance to apply and contribute to shaping the future of health research in Europe.
🔗Full call details➡️http://bit.ly/4m7fO0S
#HorizonEU
@horizoneu.bsky.social
📢€117 million in funding available under Horizon Europe's 2025 #CancerMission Work Programme.
🗓️Deadline for proposals: 16/09/25
🔗 For full info on Cancer Mission call topics see here ➡️ bit.ly/3HYeuPX
📺 Watch our Cancer Mission webinar here➡️ youtu.be/M2OulDnC_Fc?...
EATRIS is a partner of the CANDLE project, which was featured in a brief news commentary in Lancet Oncology. The article highlights the importance of establishing National #CancerData Nodes in the broader EU cancer data space.
👉 See here: https://loom.ly/82e2ghQ #CancerMission #CancerResearch
Image for promoting that the EU-CIP project was mentioned in the EU Cancer mission newsletter. The image shows a woman in professional hospital clothing in front of a microscope next to the words "thanks to you we are making the difference".
📢 EU-CIP was mentioned in the 4th EU #CancerMission newsletter:
🔗 ec.europa.eu/newsroom/rtd...
💪 Work on the EU-CIP project – to build the EU #CancerInfoPortal - is fully on track and we are closely coordinating efforts with connected projects like #CANDLE and #ECHoS
👋 Stay tuned for more
